InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Akdamar Erol R. Director active across 1 company, notably HCA Healthcare, Inc.. Aggregated, 10 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €1.6m. Activity tracked since 2 February 2023. The latest transaction was filed on 12 November 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Akdamar Erol R is a declarant and Group President at HCA Healthcare, Inc. (XNAS). Across 10 filings in total, the 10 sampled filings cover the period from 2023-02-06 to 2024-11-14, with 0 in buys and 1608716 in sells, and the recent filings include amounts of 1293275.849558571 on 2024-11-14, 1203719.780469879 on 2023-11-15, 904183.8451591377 on 2023-05-02, and 704532.4739479445 on 2023-02-06.